Marrone Bio Innovations Inc (NASDAQ:MBII) Chief Commercialization Officer Kevin Hammill revealed to Proactive results from recent yield and stress tolerance trials presented at the “Exceed The Seed” event during the recent American Seed Trade Association meeting in Chicago.